Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs

Carbohydrate Polymers

Volumn 117, Issue , 2015, Pages 577-584

  Dunnhaupt S ^a   Barthelmes, J ^a   Kollner S ^a   Sakloetsakun, D ^b   Shahnaz, G ^c   Duregger A ^d   Bernkop Schnurch A ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b KHON KAEN UNIVERSITY   (Thailand)

^c QUAID I AZAM UNIVERSITY   (Pakistan)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adhesion; Cytotoxic effects; Nanoparticles; Permeation enhancement; Polymer synthesis

Indexed keywords

NANOPARTICLES;

CYTOTOXIC EFFECTS; MACROMOLECULAR DRUGS; NANO-CARRIERS; ORAL DELIVERY; PERMEATION ENHANCEMENT; POLYMER SYNTHESIS;

ADHESION;

ACRYLIC ACID RESIN; CARBOPOL 940; CHITOSAN; DEXTRAN; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MACROMOLECULE; NANOPARTICLE; THIOL DERIVATIVE;

ANALOGS AND DERIVATIVES; CACO 2 CELL LINE; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; INTESTINE; MACROMOLECULE; ORAL DRUG ADMINISTRATION; PHARMACOLOGY; STRUCTURE ACTIVITY RELATION;

ACRYLIC RESINS; ADMINISTRATION, ORAL; CACO-2 CELLS; CELL SURVIVAL; CHITOSAN; DEXTRANS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTESTINES; MACROMOLECULAR SUBSTANCES; MOLECULAR STRUCTURE; NANOPARTICLES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFHYDRYL COMPOUNDS;

EID: 84908544524     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.09.078     Document Type: Article

References (30)

1. Anderberg, E., Nyström, C., & Artursson, P. (1992). Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. Journal of Pharmaceutical Sciences, 81(9), 879-887.
2. Andrieux, K., Lesieur, P., Lesieur, S., Ollivon, M., & Grabielle-Madelmont, C. (2002). Characterization of fluorescein isothiocyanate-dextrans used in vesicle permeability studies. Analytical Chemistry, 74(20), 5217-5226.
3. Atuma, C., Strugala, V., Allen, A., & Holm, L. (2001). The adherent gastrointestinal mucus gel layer: Thickness and physical state in vivo. American Journal of Physiology-Gastrointestinal and Liver Physiology, 280(5), G922-G929.
4. Aungst, B. J. (2000). Intestinal permeation enhancers. Journal of Pharmaceutical Sciences, 89(4), 429-442.
5. Barrett, W. C., DeGnore, J. P., König, S., Fales, H. M., Keng, Y.-F., Zhang, Z.-Y., et al. (1999). Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry, 38(20), 6699-6705.
6. Bejugam, N. K., Sou, M., Uddin, A. N., Gayakwad, S. G., & D'Souza, M. J. (2008). Effect of chitosans and other excipients on the permeation of ketotifen, FITC-dextran, and rhodamine 123 through Caco-2 cells. Journal of Bioactive and Compatible Polymers, 23(2), 187-202.
7. Bernkop-Schnürch, A. (2005). Thiomers: A new generation of mucoadhesive polymers. Advanced Drug Delivery Reviews, 57(11), 1569-1582.
8. Bernkop-Schnürch, A., Schwarz, V., & Steininger, S. (1999). Polymers with thiol groups: A new generation of mucoadhesive polymers? Pharmaceutical Research, 16(6), 876-881.
9. Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1997). Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. International Journal of Pharmaceutics, 153(1), 41-50.
10. Chang, S., Westcott, J., Henson, J., & Voelkel, N. (1987). Pulmonary vascular injury by polycations in perfused rat lungs. Journal of Applied Physiology, 62(5), 1932-1943.
11. Clausen, A., Kast, C., & Bernkop-Schnürch, A. (2002). The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharmaceutical Research, 19(5), 602-608.
12. Clausen, A. E., & Bernkop-Schnürch, A. (2001). Thiolated carboxymethylcellulose: In vitro evaluation of its permeation enhancing effect on peptide drugs. European Journal of Pharmaceutics and Biopharmaceutics, 51(1), 25-32.
13. Coupe, A., Davis, S., & Wilding, I. (1991). Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharmaceutical Research, 8(3), 360-364.
14. Decker, T., & Lohmann-Matthes, M. L. (1988). A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. Journal of Immunological Methods, 115(1), 61-69.
15. Durrer, C., Irache, J. M., Puisieux, F., Duchane, D., & Ponchel, G. (1994). Mucoadhesion of latexes. II. Adsorption isotherms and desorption studies. Pharmaceutical Research, 11(5), 680-683.
16. Greindl, M., & Bernkop-Schnürch, A. (2006). Development of a novel method for the preparation of thiolated polyacrylic acid nanoparticles. Pharmaceutical Research, 23(9), 2183-2189.
17. Hilgers, A. R., Conradi, R. A., & Burton, P. S. (1990). Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharmaceutical Research, 7(9), 902-910.
18. Hombach, J., & Bernkop-Schnürch, A. (2009). Chitosan solutions and particles: Evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model. International Journal of Pharmaceutics, 376(1-2), 104-109.
19. Kast, E. C., & Bernkop-Schnürch, A. (2002). Influence of the molecular mass on the permeation enhancing effect of different poly(acrylates). STP Pharma Sciences, 12(6), 351-356.
20. Kast, C. E., & Bernkop-Schnürch, A. (2001). Thiolated polymers - Thiomers: Development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials, 22(17), 2345-2352.
21. Kotzé, A. F., Lueßen, H. L., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1999). Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments. European Journal of Pharmaceutical Sciences, 7(2), 145-151.
22. Lueßen, H. L., de Leeuw, B. J., Langemëyer, M. W. E., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1996). Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharmaceutical Research, 13(11), 1668-1672.
23. Makhlof, A., Werle, M., Tozuka, Y., & Takeuchi, H. (2011). A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. Journal of Controlled Release, 149(1), 81-88.
24. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65(1-2), 55-63.
25. Ponchel, G., & Irache, J.-M. (1998). Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Advanced Drug Delivery Reviews, 34(2-3), 191-219.
26. Samstein, R. M., Perica, K., Balderrama, F., Look, M., & Fahmy, T. M. (2008). The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials, 29(6), 703-708.
27. Schipper, N. G. M., Olsson, S., Hoogstraate, J. A., deBoer, A. G., Va˚rum, K. M., & Artursson, P. (1997). Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharmaceutical Research, 14(7), 923-929.
28. van der Merwe, S. M., Verhoef, J. C., Verheijden, J. H. M., Kotzé, A. F., & Junginger, H. E. (2004). Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. European Journal of Pharmaceutics and Biopharmaceutics, 58(2), 225-235.
29. Werle, M., & Hoffer, M. (2006). Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. Journal of Controlled Release, 111(1-2), 41-46.
30. Wilson, J. M., Bayer, R. J., & Hupe, D. J. (1977). Structure-reactivity correlations for the thiol-disulfide interchange reaction. Journal of the American Chemical Society, 99(24), 7922-7926.